2 completed. 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Completed 2 |
Follow Cognitive Impairments: new trials by email Literature Review of Cognitive Impairments trials Research Report on Cognitive Impairments
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Attention & Memory Impairments in Menopausal Women Lisdexamfetamine, Placebo - Symptomatic Menopause, Cognitive Impairments | Phase 4 | Completed | University of Pennsylvania | 35 | 2011-05-01 | 2017-06-28 |
| Efficacy and Safety of Lisdexamfetamine Dimesylate in Adults With Chronic Fatigue Syndrome Lisdexamfetamine Dimesylate, Placebo "30, 50 or 70 mg" - Chronic Fatigue Syndrome, Cognitive Impairments | Phase 4 | Completed | Rochester Center for Behavioral Medicine | 26 | 2009-11-01 | 2025-09-09 |
Cognitive Dysfunction (2) · Fatigue Syndrome, Chronic (1)
Cognition Disorders (2) · Mental Disorders (2) · Neurocognitive Disorders (2) · Chronic Disease (1) · Disease Attributes (1) · Encephalomyelitis (1) · Muscular Diseases (1) · Musculoskeletal Diseases (1) · Nervous System Diseases (1) · Neuroinflammatory Diseases (1) · Neuromuscular Diseases (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1)
Lisdexamfetamine Dimesylate (2) · Sugars (1)
Rochester Center for Behavioral Medicine (1) · University of Pennsylvania (1)
United States (2)
Cynthia N Epperson, MD (1) · Joel L. Young, M.D. (1)